Features of the course of community-acquired pneumonia in children before and during the COVID-19 pandemic

Introduction. The basis of the work was a retrospective analysis of the course of community-acquired pneumonia (CAP) in children with COVID-19. 

Aim. To determine the features of the course of CAP before and during the COVID-19 pandemic in children from birth to 18 years.

Materials and methods. A retrospective analysis of the medical records of ninety five children (n = 95) who were treated at the Speransky Children’s Hospital No. 9 before the pandemic (October–November 2019; n = 45) and during the COVID-19 pandemic (April–May 2020 and October–November 2020; n = 50). All the received data are processed statistically.

Results. It was found that before the COVID-19 pandemic, mainly adolescents aged 13–17 years were ill, during the pandemic younger children (6–12 years old) became ill more often. With the onset of the pandemic, the course of CAP changed significantly: fever, cough, shortness of breath were typical clinical signs; local signs were more pronounced in children during the pandemic: weakened and hard breathing was more often detected. Leukocytosis and accelerated ESR prevailed in patients with CAP before the pandemic. At the same time, CRP was a more sensitive marker of inflammation. It was revealed that with the beginning of the COVID-19 pandemic, the number of atypical pneumonia decreased, which may be due to anti-epidemic measures, but the preva­lence of pneumonia of unknown etiology increased. Decreased oxygen saturation was a more frequent rule in CAP during the pandemic. Lobar pneumonia prevailed in children before the pandemic, and polysegmental pneumonia prevailed in patients during the pandemic. 

Conclusion. The features presented by the authors of the manifestations of community-acquired pneumonia in children before and during the COVID-19 pandemic make it possible to optimize their diagnosis using clinical and laboratory signs.

Contribution:
Savelyeva E.I., Gadetskaya S.G. — research concept and design of the study, collection and processing of material;
Savelyeva E.I. — statistical processing, text writing;
Korsunskiy A.A. — editing.
All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article. 

Acknowledgment. The study had no sponsorship.

Conflict of interest. The authors declare no conflict of interest.

Received: May 30, 2022
Accepted: June 10, 2022
Published: July 14, 2022

1. Leung A.K.C., Wong A.H.C., Hon K.L. Community-acquired pneumonia in children. Recent Pat. Inflamm. Allergy Drug Discov. 2018; 12(2): 136–44. https://doi.org/10.2174/1872213X12666180621163821

2. Yun K.W., Wallihan R., Juergensen A., Mejias A., Ramilo O. Community-acquired pneumonia in children: myths and facts. Am. J. Perinatol. 2019; 36(S 02): S54–7. https://doi.org/10.1055/s-0039-1691801

3. Nascimento-Carvalho C.M. Community-acquired pneumonia among children: the latest evidence for an updated management. J. Pediatr. (Rio J.). 2020; 96(Suppl. 1): 29–38. https://doi.org/10.1016/j.jped.2019.08.003

4. Tatochenko V.K. Community-acquired pneumonia in children – problems and solutions. Rossiyskiy vestnik perinatologii i pediatrii. 2021; 66(1): 9–21. https://doi.org/10.21508/1027-4065-2021-66-1-9-21 (in Russian)

5. le Roux D.M., Zar H.J. Community-acquired pneumonia in children – a changing spectrum of disease. Pediatr. Radiol. 2017; 47(11): 1392–8. https://doi.org/10.1007/s00247-017-3827-8

6. Dias C.F., Sarria E.E., Scheffel C., Delatorre L.B., Sapiro A., Baldissera M., et al. COVID-19 prevention policies reduce pediatric hospital mortality due to community-acquired pneumonia. Arch. Bronconeumol. 2022; 58(2): 197–9. https://doi.org/10.1016/j.arbres.2021.09.010

7. Stadler J.A.M., Andronikou S., Zar H.J. Lung ultrasound for the diagnosis of community-acquired pneumonia in children. Pediatr. Radiol. 2017; 47(11): 1412–9. https://doi.org/10.1007/s00247-017-3910-1

8. Kutty P.K., Jain S., Taylor T.H., Bramley A.M., Diaz M.H., Ampofo K., et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia. Clin. Infect. Dis. 2019; 68(1): 5–12. https://doi.org/10.1093/cid/ciy419

9. Mancino E., Cristiani L., Pierangeli A. A single centre study of viral community-acquired pneumonia in children: No evidence of SARS-CoV-2 from October 2019 to March 2020. J. Clin. Virol. 2020; 128: 104385. https://doi.org/10.1016/j.jcv.2020.104385

10. Protasova I.N., Per’yanova O.V., Il’enkova O.V. Etiological diagnosis of community-acquired pneumonia in children. Pul’monologiya. 2014; (5): 78–82. (in Russian)

11. Ploskireva A.A., Khlypovka Yu.N., Yatsyshina S.B., Nikolaeva S.V., Gorelov A.V. Etiology of community-acquired pneumonia in children. Russkiy meditsinskiy zhurnal. Meditsinskoe obozrenie. 2018; 2(8-2): 50–4. (in Russian)

12. Florin T.A., Ambroggio L., Brokamp C., Zhang Y., Rattan M., Crotty E., et al. Biomarkers and disease severity in children with community-acquired pneumonia. Pediatrics. 2020; 145(6): e20193728. https://doi.org/10.1542/peds.2019-3728

13. de Benedictis F.M., Kerem E., Chang A.B., Colin A.A., Zar H.J., Bush A. Complicated pneumonia in children. Lancet. 2020; 396(10253): 786–98. https://doi.org/10.1016/S0140-6736(20)31550-6

14. Zaytseva S.V., Zaytseva O.V., Lokshina E.E. Diagnosis and antibacterial treatment for community-acquired pneumonia in children during the COVID-19 pandemic. RMZh. Mat’ i ditya. 2021; 4(1): 70–6. https://doi.org/10.32364/2618-8430-2021-4-1-70-76 (in Russian)

15. Leshchenko I.V., Tsar’kova S.A., Lapshin M.A., Aristarkhova A.M. Lung damage caused by COVID-19 and community-acquired pneumonia in children: Comparative clinical and laboratory analysis. Pul’monologiya. 2021; 31(3): 296–303. https://doi.org/10.18093/0869-0189-2021-31-3-296-303 (in Russian)

16. Kohns Vasconcelos M., Weil K., Vesterling-Hörner D., Klemm M., El Scheich T., Renk H., et al. Paediatric primary care in Germany during the early COVID-19 pandemic: the calm before the storm. Fam. Med. Community Health. 2021; 9(2): e000919. https://doi.org/10.1136/fmch-2021-000919

17. Zimmerman K.O., Akinboyo I.C., Brookhart M.A., Boutzoukas A.E., McGann K.A., Smith M.J., et al. Incidence and secondary transmission of SARS-CoV-2 infections in schools. Pediatrics. 2021; 147(4): e2020048090. https://doi.org/10.1542/peds.2020-048090

18. Huang C. Pediatric non-COVID-19 community-acquired pneumonia in COVID-19 pandemic. Int. J. Gen. Med. 2021; 14: 7165–71. https://doi.org/10.2147/IJGM.S333751

19. Chiapinotto S., Sarria E.E., Mocelin H.T., Lima J.A.B., Mattiello R., Fischer G.B. Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses. Paediatr. Respir. Rev. 2021; 39: 3–8. https://doi.org/10.1016/j.prrv.2021.04.003

20. Guo Y., Xia W., Peng X., Shao J. Features discriminating COVID-19 from community-acquired pneumonia in pediatric patients. Front. Pediatr. 2020; 8: 602083. https://doi.org/10.3389/fped.2020.602083

21. Rybak A., Yang D.D., Schrimpf C., Guedj R., Levy C., Cohen R., et al. Fall of community-acquired pneumonia in children following COVID-19 non-pharmaceutical interventions: a time series analysis. Pathogens. 2021; 10(11): 1375. https://doi.org/10.3390/pathogens10111375

22. Ladhani S.N.; sKIDs Investigation Team. Children and COVID-19 in schools. Science. 2021; 374(6568): 680–2. https://doi.org/10.1126/science.abj2042

23. Lordan R., FitzGerald G.A., Grosser T. Reopening schools during COVID-19. Science. 2020; 369(6508): 1146. https://doi.org/10.1126/science.abe5765

24. Irfan O., Li J., Tang K., Wang Z., Bhutta Z.A. Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis. J. Glob. Health. 2021; 11: 05013. https://doi.org/10.7189/jogh.11.05013

25. Cheng Y., Cheng Y., Dai S., Hou D., Ge M., Zhang Y., et al. The prevalence of mycoplasma pneumoniae among children in Beijing before and during the COVID-19 pandemic. Front. Cell Infect. Microbiol. 2022; 12: 854505. https://doi.org/10.3389/fcimb.2022.854505

26. Zimmerman K.O., Brookhart M.A., Kalu I.C., Boutzoukas A.E., McGann K.A., Smith M.J., et al. Community SARS-CoV-2 surge and within-school transmission. Pediatrics. 2021; 148(4): e2021052686. https://doi.org/10.1542/peds.2021-052686

27. Roh E.J., Lee M.H., Lee J.Y., Kim H.B., Ahn Y.M., Kim J.K., et al. Analysis of national surveillance of respiratory pathogens for community-acquired pneumonia in children and adolescents. BMC Infect. Dis. 2022; 22(1): 330. https://doi.org/10.1186/s12879-022-07263-z

28. Wang M., Zhu Q., Fu J., Liu L., Xiao M., Du Y. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity. Infect. Genet. Evol. 2020; 85: 104511. https://doi.org/10.1016/j.meegid.2020.104511

29. Liu K.C., Xu P., Lv W.F., Chen L., Qiu X.H., Yao J.L., et al. Differential diagnosis of coronavirus disease 2019 from community-acquired-pneumonia by computed tomography scan and follow-up. Infect. Dis. Poverty. 2020; 9(1): 118. https://doi.org/10.1186/s40249-020-00737-9

30. Bellini T., Rotulo G.A., Caruggi S., Carta S., Bonato I., Piccotti E. Characteristics of COVID-19 patients up to 6 months of age admitted to a paediatric emergency department. Acta Paediatr. 2022; 111(2): 272–4. https://doi.org/10.1111/apa.1616